Planning Grant for Institutional Clinical and Translational Science Award

描述（由申请人提供）：我们建议在南加州大学（USC）的临床和转化科学研究所或中心和两个参与机构，洛杉矶儿童医院（CHLA）和希望之城（COH）医疗中心制定一个机构临床和转化科学奖的内容，治理，管理和评估计划。这些机构拥有广泛的高质量基础、转化、临床和社区研究和培训项目，但目前还没有整合或协调这些项目，以开展高效和有效的从临床到床边或从床边到社区的研究。正式的战略规划过程正在与学术顾问进行磋商，AMC战略：(A)第一阶段：初步研究即将完成，并将通过教师访谈，撤退和环境评估，提供定性和定量信息的基础，我们可以从中制定开发CTSA应用程序的具体目标，战略和战术；(b)第二阶段：(c)第三阶段：战略和战术的发展——将由一个指导委员会监督，与AMC战略合作，并由四个设计团队负责，以解决CTSA的主要功能组成部分。设计团队将提出正式的战略和战术建议。(d)第四阶段：最终战略计划：设计团队和AMC战略将制定最终战略计划，确定实施该计划所需的资源，制定详细的实施计划，并将计划传达给参与机构的关键选区。(e)拨款写作：根据战略计划和资源需求，首席研究员、联合研究人员和指导委员会将准备向NIH申请CTSA（预计2007年初）。这一规划过程得到了参与机构的领导和教职员工的广泛支持，并承诺为南加州大学、CHLA和COH医学中心的临床和转化科学学术之家制定一个强有力的计划。

DESCRIPTION (provided by applicant): We propose to develop a plan for the content, governance, administration and evaluation of an Institutional Clinical and Translational Science Award in an Institute or Center of Clinical and Translational Sciences at the University of Southern California (USC) and two participating institutions, Children's Hospital Los Angeles (CHLA), and the City of Hope (COH) Medical Center. These institutions have a broad range of high-quality basic, translational, clinical and community research and training programs that, at present, are not integrated or coordinated to conduct efficient and effective bench to bedside or bedside to community research. A formal strategic planning process is underway in consultation with an academic consultant, AMC Strategies: (a) Phase I: Preliminary Research is nearly completed and will provide, through faculty members interviews, a retreat and an environmental assessment, a base of qualitative and quantitative information from which we can develop specific goals, strategies and tactics for development of a CTSA application, (b)Phase II: Global Directions - will result in a vision statement and clear and measurable goals for a CTSA application, (c) Phase III: Development of Strategies and Tactics - will be overseen by a Steering Committee, working with AMC Strategies, and conducted by four design teams structured to address major functional components of a CTSA. The design teams will make formal strategic and tactical recommendations, (d) Phase IV: Final Strategic Plan: The Design Team and AMC Strategies will create the final strategic plan, identify the resources that will be required to implement it, develop a detailed implementation plan, and communicate the plan to the key constituencies across the participating institutions, (e) Grant Writing: Based on the strategic plan and resource requirement, the Principal Investigator, Co-Is and Steering Committee will prepare an application to NIH for a CTSA (anticipated early 2007). This planning process has broad support among the leadership and faculty members of the participating institutions and promises to create a robust plan for an academic home for clinical and translational science at USC, CHLA and COH Medical Center.